Pulmonary Hypertension Trial, Recruiting (NCT07079592)

Pulmonary Hypertension Trial, Recruiting NCT07079592 Sponsor: National Defense Medical Center, Taiwan Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07079592 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a man or woman between 50 and 85 years old (inclusive)
You have had at least one standard heart tracing test (ECG) done within the past 3 months

Who may not be able to join:

You have been diagnosed with pulmonary hypertension (high blood pressure in the lungs) of any type classified under WHO Groups 1 through 5 (confirm with trial site)
You have been diagnosed with certain heart muscle or heart lining conditions, including hypertrophic cardiomyopathy, restrictive cardiomyopathy, constrictive pericarditis, cardiac amyloidosis, or infiltrative cardiomyopathy (confirm with trial site for exact definitions)
You have previously had a heart, lung, or combined heart-lung transplant
A heart ultrasound (echocardiogram) has shown the blood pressure in your pulmonary artery (the vessel going from the heart to the lungs) was above 50 mmHg at any point before joining
You have had a heart ultrasound (echocardiogram) performed in the 3 months before your qualifying ECG test

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chin Lin, associate professor, National Defense Medical Center, Taiwan

Phone: 886+2-87923311

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07079592

Sponsor: National Defense Medical Center, Taiwan

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 886+2-87923311

More information: https://clinicaltrials.gov/study/NCT07079592

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a man or woman between 50 and 85 years old (inclusive)
You have had at least one standard heart tracing test (ECG) done within the past 3 months

Who may not be able to join:

You have been diagnosed with pulmonary hypertension (high blood pressure in the lungs) of any type classified under WHO Groups 1 through 5 (confirm with trial site)
You have been diagnosed with certain heart muscle or heart lining conditions, including hypertrophic cardiomyopathy, restrictive cardiomyopathy, constrictive pericarditis, cardiac amyloidosis, or infiltrative cardiomyopathy (confirm with trial site for exact definitions)
You have previously had a heart, lung, or combined heart-lung transplant
A heart ultrasound (echocardiogram) has shown the blood pressure in your pulmonary artery (the vessel going from the heart to the lungs) was above 50 mmHg at any point before joining
You have had a heart ultrasound (echocardiogram) performed in the 3 months before your qualifying ECG test

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Defense Medical Center, Taiwan

Registry

ClinicalTrials.gov

Start date

1 February 2026

Est. completion

15 June 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Pulmonary arterial pressure > 50 mmHg

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov